Rao L. Divi
- Molecular Biology top 10%
- Infectious Diseases top 5%
- Cancer Research top 5%
- Oncology top 10%
- Emergency Medicine top 2%
- Co-authors
- Daniel R. DoergeMiriam C. PoirierMona I. ChurchwellHebron C. ChangMukesh VermaOfelia A. OliveroKunio NagashimaTram Kim Lam
- Topics
- HIV-related health complications and treatments (8 papers)Effects and risks of endocrine disrupting chemicals (8 papers)Carcinogens and Genotoxicity Assessment (8 papers)
- Partner nations
- United StatesMalaysiaCanada
In The Last Decade
Rao L. Divi
53 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 141
- Molecular Biology 776
- Infectious Diseases 369
- Cancer Research 354
- Oncology 261
- Emergency Medicine 248
Countries citing papers authored by Rao L. Divi
This map shows the geographic impact of Rao L. Divi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rao L. Divi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rao L. Divi more than expected).
Fields of papers citing papers by Rao L. Divi
This network shows the impact of papers produced by Rao L. Divi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rao L. Divi. The network helps show where Rao L. Divi may publish in the future.
Co-authorship network of co-authors of Rao L. Divi
This figure shows the co-authorship network connecting the top 25 collaborators of Rao L. Divi. A scholar is included among the top collaborators of Rao L. Divi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rao L. Divi. Rao L. Divi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 20 | |
| 3 | 29 | |
| 4 | 65 | |
| 5 | 16 | |
| 6 | 13 | |
| 7 | 35 | |
| 8 | 19 | |
| 9 | 40 | |
| 10 | 141 | |
| 11 | Continuous exposure to the carcinogenic antiretroviral drug Zidovudine (AZT) alters metabolism of human cells in vitro | 1 |
| 12 | 31 | |
| 13 | 50 | |
| 14 | 29 | |
| 15 | 71 | |
| 16 | 51 | |
| 17 | Formation of tamoxifen-DNA adducts in multiple organs of adult female cynomolgus monkeys dosed with tamoxifen for 30 days. | 23 |
| 18 | 149 | |
| 19 | Semiquantitation of polycyclic aromatic hydrocarbon-DNA adducts in human esophagus by immunohistochemistry and the automated cellular imaging system. | 41 |
| 20 | 194 |
About Rao L. Divi
Rao L. Divi is a scholar working on Virology, Health, Toxicology and Mutagenesis and Cancer Research, having authored 54 papers that have together received 2.3k indexed citations. Recurring topics across this work include HIV-related health complications and treatments (8 papers), Effects and risks of endocrine disrupting chemicals (8 papers) and Carcinogens and Genotoxicity Assessment (8 papers). The work is most often cited by research in Virology (197 citations), Emergency Medicine (248 citations) and Cancer Research (354 citations). Rao L. Divi has collaborated with scholars based in United States, Malaysia and Canada. Frequent co-authors include Daniel R. Doerge, Miriam C. Poirier, Mona I. Churchwell, Hebron C. Chang, Mukesh Verma, Ofelia A. Olivero, Kunio Nagashima, Tram Kim Lam, Vernon E. Walker and Vi Nguyen. Their work appears in journals such as The Journal of Immunology, JNCI Journal of the National Cancer Institute and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.